Investing.com - AtriCure reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
AtriCure announced earnings per share of $-0.27 on revenue of $83.25M. Analysts polled by Investing.com anticipated EPS of $-0.25 on revenue of $81.26M.
AtriCure shares are down 38% from the beginning of the year, still down 51.85% from its 52 week high of $89.18 set on November 5, 2021.
AtriCure follows other major Healthcare sector earnings this month
AtriCure's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar